Medical Devices & Tech

DermTech International

1020 Prospect Street, Suite 301
La Jolla, CA 92037-0068 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description DermTech International creates non-invasive tests to harvest a person's skin cells and detect disease, specifically melanoma.

Management George B. Schwartz, CEO/President; Sherman Chang, PhD, Director, Molecular Biology; Jennifer Larson, Director, Business Development Directors/Advisory Board: Boris C. Bastian, MD, PhD.; Allan C. Halpern, MD; Scott Menzies, MD, PhD; David Polsky, MD, PhD

Click here for Financial Data
Keywords: Dermatology, skin, testing, safety, dna, services, products, Diagnostics Diagnostics, Oncology, Genetic Profiling Diagnostics, Melanoma.


Updated: Oct. 28, 2015


DermTech is a La Jolla-based biotechnology company developing non-invasive tests to detect disease. Its lead product in development is MelDTect, the first genomic, non-invasive test to detect melanoma......view more

Products / Services

Melanoma Detection: Skin biopsies are commonly performed when a suspicious lesion requires further analysis to determine the presence of melanoma. Surgical techniques and devices are used to collect ......view more

Technology / Differentiation

The non-invasive EGIR (Epidermal Genetic Information Retrieval) technology platform has been developed and patented by DermTech. The technology uses a piece of custom adhesive tape applied to the out...view more

Market / Customers

Based on current American Academy of Dermatology guidelines for skin checks (for high-risk individuals) in the US and standard practice in other countries, it is estimated very conservatively that the......view more

Revenue / Funding

Funding to Date: $24 MM; Financing Sought: $12 MM....view more


The future plan is to provide a method for reliable sample collection by a broad range of medical personnel in an outpatient setting....view more

Analyst Coverage